GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (OSTO:ASAP) » Definitions » Other Long-Term Liabilities

Asarina Pharma AB (OSTO:ASAP) Other Long-Term Liabilities : kr0.00 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Asarina Pharma AB Other Long-Term Liabilities?

Asarina Pharma AB's other long-term liabilities for the quarter that ended in Dec. 2023 was kr0.00 Mil.

Asarina Pharma AB's quarterly other long-term liabilities increased from Dec. 2022 (kr-0.00 Mil) to Jun. 2023 (kr0.00 Mil) and increased from Jun. 2023 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil).

Asarina Pharma AB's annual other long-term liabilities declined from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr-0.00 Mil) but then increased from Dec. 2022 (kr-0.00 Mil) to Dec. 2023 (kr0.00 Mil).

Asarina Pharma AB Other Long-Term Liabilities Historical Data

The historical data trend for Asarina Pharma AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB Other Long-Term Liabilities Chart

Asarina Pharma AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial - - - - -

Asarina Pharma AB Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Asarina Pharma AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Asarina Pharma AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Asarina Pharma AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Asarina Pharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (OSTO:ASAP) » Definitions » Other Long-Term Liabilities
Comparable Companies
XSAT:ALTE OSTO:CYXO OSTO:DIABIO OSTO:REDW OSTO:PHARM OSTO:AMNI XSAT:PHAL OSTO:LIDDS OSTO:SPAGO OSTO:CLINE B OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65
Website
https://www.asarinapharma.com
Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB Headlines

No Headlines